BUY Quess Corp Limited — Madhu Bansal
byMadhu BansalHorizon: NA (inferred Swing (≤2wk))9 Nov 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·14 Nov · today
Past week's volume 1.7× the 30-day average
Technicals · volume·13 Nov · yesterday
Quess Corp Q2 Results: Net profit jumps 45% on staffing growth; declares ₹5 dividend
NewsCnbc-Tv18·30 Oct · 2w ago
Quess Corp reported a 44% year-on-year growth in PAT to Rs 75 crore for Q2 and reached a headcount milestone of 500,000 employees.
NSE · Press Release·30 Oct · 2w ago
Quess Corp reported Q2 FY27 financial results with revenue of ₹4,396 crore (up 15% YoY) and PAT of ₹75 crore (up 44% YoY). The company also announced an interim dividend of ₹5 per share.
BSE · Company Update·30 Oct · 2w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Quess Corp
- BUY — HDFC Securities3 Nov 2026 · ~1 year · target ₹390 · Active
- BUY — Vishnu Kant Upadhyay, Master Capital Services12 Oct 2026 · ~2 weeks · target ₹370 · SL hit
- BUY — Aastha Jain, Hem Securities26 Aug 2026 · ~2 weeks · target ₹400 · SL hit
- BUY — Nilesh Jain, Centrum Broking25 Aug 2026 · Same day · target ₹355 · Expired
- BUY — Ajit Nayak, HDFC Securities10 Aug 2026 · ~2 weeks · target ₹345 · Target hit
More from Madhu Bansal
- BUY Eris Lifesciences13 Nov 2026 · ~2 weeks · target ₹1,450 · Active
- BUY Nazara Technologies13 Nov 2026 · ~2 weeks · target ₹467 · Active
- BUY Signatureglobal (India)12 Nov 2026 · ~2 weeks · target ₹835 · Active
- BUY Shilpa Medicare12 Nov 2026 · ~2 weeks · target ₹1,050 · Active
- BUY Supriya Lifescience11 Nov 2026 · ~2 weeks · target ₹725 · SL hit

